MaxCyte(MXCT) - 2025 Q4 - Earnings Call Transcript

MaxCyte (NasdaqGS:MXCT) Q4 2025 Earnings call March 24, 2026 04:30 PM ET Speaker8Please note, this conference is being recorded. Now we'll turn the call over to Erik Abdo with Investor Relations. Please proceed.Speaker3Good afternoon, everyone. Thank you for participating in today's conference call. Joining me on the call from MaxCyte, we have Maher Masoud, President and Chief Executive Officer, Douglas Swirsky, Chief Financial Officer, and Sean Menarguez, Senior Director of Business Development. Earlier to ...